» Articles » PMID: 31845908

Ivermectin Inhibits HSP27 and Potentiates Efficacy of Oncogene Targeting in Tumor Models

Abstract

HSP27 is highly expressed in, and supports oncogene addiction of, many cancers. HSP27 phosphorylation is a limiting step for activation of this protein and a target for inhibition, but its highly disordered structure challenges rational structure-guided drug discovery. We performed multistep biochemical, structural, and computational experiments to define a spherical 24-monomer complex composed of 12 HSP27 dimers with a phosphorylation pocket flanked by serine residues between their N-terminal domains. Ivermectin directly binds this pocket to inhibit MAPKAP2-mediated HSP27 phosphorylation and depolymerization, thereby blocking HSP27-regulated survival signaling and client-oncoprotein interactions. Ivermectin potentiated activity of anti-androgen receptor and anti-EGFR drugs in prostate and EGFR/HER2-driven tumor models, respectively, identifying a repurposing approach for cotargeting stress-adaptive responses to overcome resistance to inhibitors of oncogenic pathway signaling.

Citing Articles

Advances in the structures, mechanisms and targeting of molecular chaperones.

Gu J, He Y, He C, Zhang Q, Huang Q, Bai S Signal Transduct Target Ther. 2025; 10(1):84.

PMID: 40069202 PMC: 11897415. DOI: 10.1038/s41392-025-02166-2.


Targeting WDPF domain of Hsp27 achieves a broad spectrum of antiviral.

Wu M, Li W, Leung H, Wang Y, Wan Q, Chen P MedComm (2020). 2025; 6(3):e70032.

PMID: 40013315 PMC: 11862887. DOI: 10.1002/mco2.70032.


Prognostic value of HSP27 in 28-day mortality in septic ICU patients: a retrospective cohort study.

Yao L, Fan Z, Yao F, Wang X Front Med (Lausanne). 2025; 11():1513788.

PMID: 39850096 PMC: 11755344. DOI: 10.3389/fmed.2024.1513788.


O-GlcNAc modification of HSP27 alters its protein interactions and promotes refolding of proteins through the BAG3/HSP70 co-chaperone.

Javed A, Johnson O, Balana A, Volk R, Langen A, Ahn B Protein Sci. 2024; 33(10):e5173.

PMID: 39291732 PMC: 11409196. DOI: 10.1002/pro.5173.


The biphasic role of Hspb1 on ferroptotic cell death in Parkinson's disease.

Meng J, Fang J, Bao Y, Chen H, Hu X, Wang Z Theranostics. 2024; 14(12):4643-4666.

PMID: 39239519 PMC: 11373631. DOI: 10.7150/thno.98457.


References
1.
. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 5):760-3. DOI: 10.1107/S0907444994003112. View

2.
Wang J, Wolf R, Caldwell J, Kollman P, Case D . Development and testing of a general amber force field. J Comput Chem. 2004; 25(9):1157-74. DOI: 10.1002/jcc.20035. View

3.
Rosenberg J, Hahn N, Regan M, Werner L, Alva A, George S . Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2). Br J Cancer. 2018; 118(11):1434-1441. PMC: 5988804. DOI: 10.1038/s41416-018-0087-9. View

4.
Hochberg G, Ecroyd H, Liu C, Cox D, Cascio D, Sawaya M . The structured core domain of αB-crystallin can prevent amyloid fibrillation and associated toxicity. Proc Natl Acad Sci U S A. 2014; 111(16):E1562-70. PMC: 4000792. DOI: 10.1073/pnas.1322673111. View

5.
Shin K, Lee M, Shin D, Lee S, Son K, Koh S . Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J Biol Chem. 2005; 280(50):41439-48. DOI: 10.1074/jbc.M507209200. View